Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomall...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/8/2/18 |
id |
doaj-5cb614e3d6844876a87ffeccc0c9f8cf |
---|---|
record_format |
Article |
spelling |
doaj-5cb614e3d6844876a87ffeccc0c9f8cf2020-11-25T01:30:18ZengMDPI AGPharmaceutics1999-49232016-05-01821810.3390/pharmaceutics8020018pharmaceutics8020018Current Trends in Development of Liposomes for Targeting Bacterial BiofilmsZora Rukavina0Željka Vanić1Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, CroatiaDepartment of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, CroatiaBiofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomally-associated nanomicrobials, presents a promising approach for improved drug delivery to bacterial cells and biofilms. Versatile manipulations of liposomal physicochemical properties, such as the bilayer composition, membrane fluidity, size, surface charge and coating, enable development of liposomes with desired pharmacokinetic and pharmacodynamic profiles. This review attempts to provide an unbiased overview of investigations of liposomes destined to treat bacterial biofilms. Different strategies including the recent advancements in liposomal design aiming at eradication of existing biofilms and prevention of biofilm formation, as well as respective limitations, are discussed in more details.http://www.mdpi.com/1999-4923/8/2/18liposomesbiofilmantimicrobialinfectiondrug deliveryphysicochemical properties |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zora Rukavina Željka Vanić |
spellingShingle |
Zora Rukavina Željka Vanić Current Trends in Development of Liposomes for Targeting Bacterial Biofilms Pharmaceutics liposomes biofilm antimicrobial infection drug delivery physicochemical properties |
author_facet |
Zora Rukavina Željka Vanić |
author_sort |
Zora Rukavina |
title |
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms |
title_short |
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms |
title_full |
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms |
title_fullStr |
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms |
title_full_unstemmed |
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms |
title_sort |
current trends in development of liposomes for targeting bacterial biofilms |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2016-05-01 |
description |
Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomally-associated nanomicrobials, presents a promising approach for improved drug delivery to bacterial cells and biofilms. Versatile manipulations of liposomal physicochemical properties, such as the bilayer composition, membrane fluidity, size, surface charge and coating, enable development of liposomes with desired pharmacokinetic and pharmacodynamic profiles. This review attempts to provide an unbiased overview of investigations of liposomes destined to treat bacterial biofilms. Different strategies including the recent advancements in liposomal design aiming at eradication of existing biofilms and prevention of biofilm formation, as well as respective limitations, are discussed in more details. |
topic |
liposomes biofilm antimicrobial infection drug delivery physicochemical properties |
url |
http://www.mdpi.com/1999-4923/8/2/18 |
work_keys_str_mv |
AT zorarukavina currenttrendsindevelopmentofliposomesfortargetingbacterialbiofilms AT zeljkavanic currenttrendsindevelopmentofliposomesfortargetingbacterialbiofilms |
_version_ |
1725092217773621248 |